Benzoic Acid

Benzoic Acid

SCHEMBL931656

CCOCC.O=C(O)c1ccccc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.64
DAO P14920 1/20 0.64
NAPRT Q6XQN6 1/20 0.64
CES2 O00748 3/20 0.54
CES1 P23141 3/20 0.54
SRD5A2 P31213 1/20 0.54
ALDH1A1 P00352 2/20 0.50
PKM P14618 1/20 0.48
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
MRGPRX4 Q96LA9 1/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
PLA2G4B P0C869 1/20 0.47
MAPT P10636 1/20 0.47
KDM4E B2RXH2 1/20 0.46
POLB P06746 1/20 0.46
RXRA P19793 1/20 0.46
RXRB P28702 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL9460609 1.00 TSHR (0.64) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL11650940 0.96 TSHR (0.58) TSHRDAONAPRTCES2CES1
Phthalic Acid SCHEMBL5078833 0.92 ALDH1A1 (0.54) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL3384089 0.91 DAO (0.58) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL1969718 0.91 DAO (0.58) TSHRDAONAPRTCES2CES1
Terephthalic Acid SCHEMBL2264605 0.91 TSHR (0.60) TSHRSRD5A2ALDH1A1TP53KMT2A
Benzoic Acid SCHEMBL11359135 0.90 DAO (0.52) TSHRDAONAPRTCES2CES1
Isophthalic Acid SCHEMBL1557618 0.87 KMT2A (0.56) PKMTP53MRGPRX4KMT2ANPC1
Benzil SCHEMBL2684477 0.86 CES2 (0.64) CES2CES1ALDH1A1LMNAMAPT
Benzophenone SCHEMBL1147611 0.86 ALDH1A1 (0.64) CES2CES1SRD5A2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116621910-A Artificial potassium ion transporter with anti-hepatic fibrosis activity and preparation method and application thereof 厦门大学 2023-08-22 CN claimed
CN-102453149-A Olefin polymerization catalyst component, olefin polymerization catalyst, and olefin polymerization method CHINA PETROLEUM & CHEMICAL 2012-05-16 CN claimed
EP-1861458-A1 FLAME RETARDANTS AND FLAME RETARDED POLYMERS GREAT LAKES CHEMICAL CORPORATION (US) 2007-12-05 EP claimed
WO-2006102138-A1 FLAME RETARDANTS AND FLAME RETARDED POLYMERS GREAT LAKES CHEMICAL CORPORATION (US) 2006-09-28 WO claimed
US-6835374-B2 Fine particle size; mixing, suspension active material with surfactant REHEIS, INC. 2004-12-28 US claimed
EP-1417953-A2 Novel antiperspirant/deodorant active for no white residue sticks and soft solids REHEIS, INC. (US) 2004-05-12 EP claimed
US-20040081632-A1 Novel antiperspirant/deodorant active for no white residue sticks and soft solids SUMMIT RESEARCH LABS, INC. 2004-04-29 US claimed
US-4306933-A Tin/tin-lead stripping solutions CHEMLINE INDUSTRIES (US) 1981-12-22 US claimed
JP-10044615-A None JP disclosed
WO-2024071313-A1 COSMETIC COMPOSITION AND COSMETIC 株式会社日本触媒 2024-04-04 WO disclosed
US-20240051979-A1 TREPROSTINIL PRODRUGS UNITED THERAPEUTICS CORPORATION (US) 2024-02-15 US disclosed
US-20240009092-A1 COSMETIC COMPOSITION AND COSMETIC QUASI-DRUG INCLUDING LIPID PARTICLES CONTAINING PHOSPHOLIPID NIPPON SHOKUBAI CO., LTD. (JP) 2024-01-11 US disclosed
WO-2023230470-A1 SURFACTANT COMPRISING POLYOL/ MONOOL - EPOXY PRODUCTS AND ITS PROCESS FOR PREPARATION, COMPOSITION AND METHOD OF USE THEREOF HERCULES LLC (US) 2023-11-30 WO disclosed
CN-116621910-A Artificial potassium ion transporter with anti-hepatic fibrosis activity and preparation method and application thereof 厦门大学 2023-08-22 CN disclosed
US-5919970-A Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity ALLERGAN SALES, INC. (US) 1999-07-06 US disclosed
WO-1998048768-A1 COMPOSITIONS FOR COSMETIC APPLICATIONS MEDLOGIC GLOBAL CORPORATION (US) 1998-11-05 WO disclosed
JP-H1044615-A MICROCAPSULE COMPOSITION OF THERMAL DEGRADATION PROPERTIES AND HEAT-SENSITIVE MATERIAL MITSUBISHI PAPER MILLS LTD 1998-02-17 JP disclosed
EP-0409382-A1 Glutamic acid derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1991-01-23 EP disclosed
WO-1990014340-A1 GLUTAMIC ACID DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1990-11-29 WO disclosed
US-4921836-A ANTITUMOR AGENTS BURROUGHS WELLCOME CO. (US) 1990-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240009092-A1 COSMETIC COMPOSITION AND COSMETIC QUASI-DRUG INCLUDING LIPID PARTICLES CONTAINING PHOSPHOLIPID PLIN5, PHOSPHO1, PLIN3 TSHR 1575/4885DAO 4127/4885NAPRT 1921/4885
US-20240051979-A1 TREPROSTINIL PRODRUGS TYMP, TK1, DCTPP1 TSHR 1445/4885DAO 1459/4885NAPRT 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.